Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pexelizumab on mortality and MI in CABG surgery patients
NCT00048308Phase 3Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jan 2002
- Primary completion
- Mar 2003
- Modality
- Antibody Fragments, Antibody Conjugates, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of pexelizumab in myocardial infarction (MI), all-cause mortality (ACM), sponsored by Alexion Pharmaceuticals. Started Jan 2002; status: completed.
02
Drugs
pexelizumab
03
Conditions
myocardial infarction (MI)all-cause mortality (ACM)
Beyond the preview
Go deeper on NCT00048308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048308.